JPMorgan Chase profit beat estimates

The World's First "$20 Trillion Drug?" One small biotech holds the key to a revolution in treating Alzheimer's disease. Jeff Bezos, Goldman Sachs & Big Pharma giants have invested billions into this unknown biotech. Our research proves that anyone who gets in today could see 113,000% gains! Get the name of the stock here >>> [ad] Banking Nightmare During and after the Great Financial Crisis of 2008, 485 U.S. banks went under. Weiss Ratings warned about 484 — an accuracy rate of 99.8% Now, Dr. Martin Weiss has a new warning. But this time, it's not just about a few hundred banks. It's about nearly every single bank in America, whether large or small. A veritable banking nightmare! See what it is here. [ad] Unexpected gains from AI stocks Multimillionaire trader Nate Bear just shocked the investing world during a recent demonstration and it's causing AI stocks like NVDA to surge to new heights. Research found that in just one month, smart investors could have made top gains of 443% in 11 days, 543% in nine days, and 88% in seven days...All by trading just one ticker a week! Click here to see the proof for yourself. [ad] UnitedHealth profit beats on lower-than-feared medical costs The healthcare conglomerate's shares rose nearly 2% to $534.06 in premarket trading. Insurers had benefited from a delay in non-urgent surgeries during the pandemic, with hospitals also grappling with staffing shortages. Read more here… JPMorgan Chase profit, adjusted revenue beat estimates amid higher interest rates Adjusted revenue in the three-month period came in at $40.7 billion, beating Bloomberg consensus estimates of $39.9B. The figure was down slightly from $42.0B in the second quarter, but surged by 21% year-on-year. Read more here… DISCLAIMER: Stocks and options trading have large potential rewards, but also large potential risk. You must be aware of the risks and be willing to accept them in order to invest in the stocks and options markets. Don't trade with money you can't afford to lose. This is neither a solicitation nor an offer to Buy/Sell stocks or options. No representation is being made that any account will or is likely to achieve profits or losses similar to those discussed in this report. The past performance of any trading system or methodology is not necessarily indicative of future results. All trades, patterns, charts, systems, etc., discussed in this report are for illustrative purposes only and not to be construed as specific advisory recommendations. Information contained in this correspondence is intended for informational purposes only and was obtained from sources believed to be reliable. Information is in no way guaranteed. No guarantee of any kind is implied or possible where projections of future conditions are attempted.

2563 cherry hill ln, Hermitage, PA 16148, United States You may unsubscribe or change your contact details at any time. Powered by: